We had reported that GAS5 expression was negatively correlated with worse clinical characteristics in NSCLC specimens previously, including tumor size and TNM stage [16], and we analyzed its association with immune cell infiltration in the current study. This evidence concerns the gene GAS5 and neoplasm.